Helen McCarthy
- helen dot mccarthy at rbch dot nhs dot uk
- visiting prof
Back to top
Journal Articles
- Chari, A., McCarthy, H. et al., 2021. Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study. British Journal of Haematology, 192 (5), 869-878.
- Barr, P.M., McCarthy, H. et al., 2018. Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: Extended phase 3 results from RESONATE-2. Haematologica, 103 (9), 1502-1510.